This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research.
Methods in cell biology · 2025
T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets.
Frontiers in immunology · 2023
EPH receptor tyrosine kinases phosphorylate the PAR-3 scaffold protein to modulate downstream signaling networks.
Cell reports · 2022
Latest funding
- $1,137,500
GMEB-SASS: The first clinical trial phase I/II using a genetically modified epidermolysis bullosa self-assembled skin substitute to treat dystrophic epidermolysis bullosa, a severe rare skin disease
CIHR · 2024 · Principal investigator
- $318,420
A gene therapy strategy for recessive distrophic epidermolysis bullosa
CIHR · 2013 · Nominated PI
- $93,001
Optimisation du procédé de concentration/purification de vecteurs rétroviraux produits en suspension et dans du milieu sans sérum
NSERC · 2011 · Principal investigator
18 publications.
Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research.
Stock S, Fertig L, Menkhoff VD, Strzalkowski T, Caruso M, Kobold S
T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets.
Nowill AE, Caruso M, de Campos-Lima PO
EPH receptor tyrosine kinases phosphorylate the PAR-3 scaffold protein to modulate downstream signaling networks.
Banerjee SL, Lessard F, Chartier FJM, Jacquet K, Osornio-Hernandez AI, Teyssier V, Ghani K, Lavoie N, Lavoie JN, Caruso M, Laprise P, Elowe S, Lambert JP, Bisson N
Efficient Gamma-Retroviral Transduction of Primary Human Skin Cells Using the EF-c Peptide as a Transduction Enhancer.
Barbier MA, Piaceski AD, Larouche D, Villeneuve SH, Ghani K, Pope E, Caruso M, Germain L
A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein.
Roy S, Ghani K, de Campos-Lima PO, Caruso M
Peel Test to Assess the Adhesion Strength of the Dermal-Epidermal Junction in Tissue-Engineered Skin.
Larose AE, Dakiw-Piaceski A, Barbier MA, Larouche D, Gauvin R, Caruso M, Pope E, Germain L
Generation of High-Titer Self-Inactivated γ-Retroviral Vector Producer Cells.
Ghani K, Boivin-Welch M, Roy S, Dakiw-Piaceski A, Barbier M, Pope E, Germain L, Caruso M
The size of the unbranched aliphatic chain determines the immunomodulatory potency of short and long chain n-alkanols.
Carignan D, Désy O, Ghani K, Caruso M, de Campos-Lima PO
Nilotinib and imatinib inhibit cytarabine cellular uptake: implications for combination therapy.
Naud JS, Ghani K, de Campos-Lima PO, Caruso M
A dominant-negative approach that prevents diphthamide formation confers resistance to Pseudomonas exotoxin A and diphtheria toxin.
Roy V, Ghani K, Caruso M
GMEB-SASS: The first clinical trial phase I/II using a genetically modified epidermolysis bullosa self-assembled skin substitute to treat dystrophic epidermolysis bullosa, a severe rare skin disease
Principal investigators: Germain, Lucie; Pope, Elena; Caruso, Manuel P; Fradette, Julie; Guertin, Jason R; Laprise, Catherine; Laurin, Mélanie; Zawati, Ma'n Hilmi M.
Keywords: Collagen; Epidermolysis Bullosa; Gene Therapy; Novel Treatment; Pediatric Disease; Rare Disease; Skin Genetic Disease; Skin Grafting; Stem Cells, Skin; Tissue Engineering
A gene therapy strategy for recessive distrophic epidermolysis bullosa
Principal investigators: Caruso, Manuel P
Keywords: Collagen; Epidermolysis Bullosa; Gene Therapy; Retroviral Vector; Skin
Optimisation du procédé de concentration/purification de vecteurs rétroviraux produits en suspension et dans du milieu sans sérum
Principal investigators: Caruso, Manuel
Identification of new genes involved in early steps of retroviral and lentiviral replication
Principal investigators: Caruso, Manuel
The biomanufacturing of retroviral and lentiviral vectors
Principal investigators: Caruso, Manuel
Développement d'un procédé complet pour la production de rétrovirus recombinants
Principal investigators: Garnier, Alain
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Chirurgie
- Molecular Medicine
- Pediatrics
- Other
Co-authors at Université Laval, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.